Dr Chris Hurt explains the current market situation.

“Producers are compensating for the smaller head count with sharp increases in market weights,” said Dr Hurt. “As producers experience record profits – more than $70 per head on average for the six-month period – they’re also increasing the time pigs stay on feed.”

Today, producers are taking market-ready pigs from recent historical weights of 265lbs. to as high as 325lbs.

As producers put more into their finishing groups, late-stage production losses become an even more serious issue, as the value of a pig approaches $300 in today’s market, which is well above the price seen last year.

In a barn of 1,000 pigs, if just one 325-lb. pig is saved (with carcass prices at $1.24 per lb.), the benefit is nearly $300, or $0.30 per pig for the entire group.

With the threat of increased late-stage mortality, protecting pigs all the way through the finishing phase to market is crucial to the economic success of a producer.

Circumvent® G2 is the only vaccine with five-month PCV2 duration of immunity (DOI), which is 25 per cent longer than any other PCV2 vaccine on the market.

The additional four weeks of immunity that Circumvent G2 vaccination provides means better protection in late stages of production where the loss of pigs approaching market weight can be devastating.

In addition, by effectively controlling circovirus, the pigs in your operation will have a stronger immune system and better defence against co-infections from Porcine Reproductive and Respiratory Syndrome (PRRS), Mycoplasma hyopneumoniae and swine influenza virus (SIV), which can contribute to late-finishing mortality.

For prescribing information for Circumvent G2, visit www.circumvent-g2.com.